Pliant Therapeutics, Inc. (PLRX) Tops Q4 EPS by 17c

Pliant Therapeutics, Inc. (NASDAQ: PLRX) reported Q4 EPS of ($0.82), $0.17 better than the analyst estimate of ($0.99).

For earnings history and earnings-related data on Pliant Therapeutics, Inc. (PLRX) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Beike (BEKE) PT Raised to $23 at Morgan Stanley
• Jefferies: US equity ETF inflows jump to $27.8B on strong demand